CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 207 enrolled
Drug / intervention
Apollo Evolution Investigational BG Monitoring Systemdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT01466075
NCT01466075N/ACompleted
CompareCT.gov

Clinical Study of the Apollo Evolution BGMS With Tatsu Blood Glucose Test Strips

Ascensia Diabetes Care·interventional·Posted Nov 7, 2011·Updated Feb 29, 2016

In Brief

A clinical study evaluating Apollo Evolution Investigational BG Monitoring System for Diabetes. Completed, enrolled 207 participants across 1 site.

Detailed Summary

The purpose of this study is to demonstrate that untrained subjects who have diabetes or pre-diabetes can operate the investigational Blood Glucose Monitoring System (BGMS) and obtain valid glucose results.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDiabetes
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedNov 7, 2011
Enrollment StartNov 1, 2011
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 1 monthPosted 14.7 years ago

Interventions

Apollo Evolution Investigational BG Monitoring Systemdevice

Untrained subjects with diabetes perform self Blood Glucose (BG) tests with capillary fingerstick blood and Alternative Site Testing (AST) of the palm using the Apollo Evolution meter and an investigational sensor. Study staff test subject venous blood and all BG results are compared to a reference laboratory glucose method. Untrained subjects complete basic tasks using the User Guide and provide feedback.